Clinical Trial Results TV
Trial / Study: 816 submissions (showing 661 to 675)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44 | Page 45 | Page 46 | Page 47 | Page 48 | Page 49 | Page 50 | Page 51 | Page 52 | Page 53 | Page 54 | Page 55 |

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Christopher Cannon and Dr. C. Michael Gibson discuss the PCI findings of the PLATO trial
Dr. Christopher P. Cannon, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Cannon and Dr. Gibson discuss the COGENT Trial and the limitations of observational data
Dr. Christopher P. Cannon, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the results of the COGENT Trial
Dr. Deepak Bhatt, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the results of the CHARISMA Genomics Substudy
Dr. Deepak Bhatt, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. David Cohen and Dr. C. Michael Gibson discuss the TRITON-TIMI 38 Economic Substudy
Dr. David Cohen, MD, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Junbo Ge and Dr. C. Michael Gibson discuss the results of the NO REFLOW Trial
Dr. C. Michael Gibson, MD, Dr. Ge Junbo

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Sanjay Kaul and Dr. C. Michael Gibson discuss the findings of the PLATO trial
Dr. Sanjay Kaul, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Flavio Ribichini and Dr. C. Michael Gibson discuss the results of the CEREA-DES Trial
Dr. C. Michael Gibson, MD, Dr. Flavio Ribichini

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Josef Veselka and Dr. C. Michael Gibson discuss the STATINS PRE-PCI Trial
Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Robert Byrne and Dr. C. Michael Gibson discuss the ISAR-DESIRE 2 Trial
Dr. Robert Byrne, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Stephan Windecker and Dr. C. Michael Gibson discuss the results of the SIRTAX-LATE Trial from TCT 2009
Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. William Fearon and Dr. C. Michael Gibson discuss the 2-year results of the FAME Study from TCT 2009
Dr. C. Michael Gibson, , Dr. William Fearon

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Harrington and Dr. Gibson discuss the role of CRP in cardiovascular disease
Dr. Robert Harrington, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Drs. Harrington and Gibson discuss the clinical implications of vulnerable plaque and arterial wall remodeling on CTA
Dr. Robert Harrington, MD, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Drs. Harrington and Gibson discuss the BARI 2D trial, factor 10a inhibitors, and the need for more sensitive bleeding me
Dr. Robert Harrington, MD, Dr. C. Michael Gibson, MD